Semaglutide 20mg
Single-pathway GLP-1 receptor agonist research compound
Ordering is not open
PepGo is not accepting orders while its controlled pre-launch checks are in progress.
Specification
- Purity
- ≥99% (HPLC/MS)
- Size
- 20mg
- Molecular Weight
- 4,113.6 g/mol
- CAS
- 910463-68-2
- Catalog No.
- PG-SEMA-020
- Form
- Lyophilized powder
- Storage
- -20°C, protect from light
Overview
Semaglutide is a 31-amino-acid synthetic peptide analog of the native GLP-1 backbone, engineered with Aib at position 8 and a C18 fatty diacid side chain for albumin binding and extended half-life.
Mechanism
Single-pathway GLP-1 receptor agonist research compound
Research Note
Studied in preclinical and laboratory models for receptor binding kinetics, downstream cAMP/PKA signaling, and as the single-pathway reference against dual- and triple-agonist compounds.
References
- [1]Lau J. et al. (2015). J Med Chem 58(18):7370–7380
- [2]Marso S.P. et al. (2016). NEJM 375:1834–1844
Research Use Only
This product is a chemical reagent for in-vitro laboratory research only. It is not for human or veterinary use, consumption, or any diagnostic or clinical application.
Storage & Handling
Storage
Store sealed at -20°C, protected from light and moisture, until laboratory use. Reseal and return to cold storage promptly after handling.
Handling
Supplied as a lyophilized powder intended for in-vitro laboratory use. Handle with standard laboratory PPE and technique appropriate to your research protocol.
Stability
Stable as a lyophilized powder under recommended storage conditions through the labeled use-by date. Post-preparation stability depends on the buffer and conditions selected by the researcher.
Frequently Asked Questions
For Research Use Only. Not for human or veterinary use. Products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.